Johnson & Johnson Q4 2020 Earnings Report

Reported fourth-quarter and full year results for 2020.

Key Takeaways

Johnson & Johnson reported Q4 2020 sales of $22.5 billion, reflecting growth of 8.3%. The company's EPS was $0.65, a decrease of 56.7%, while adjusted EPS was $1.86, a decrease of 1.1%. Full-year sales were $82.6 billion, and the company provided 2021 guidance of adjusted operational sales growth of 8.8% and adjusted operational EPS growth of 16.4%.

Fourth-quarter sales reached $22.5 billion, reflecting 8.3% growth.

Full-year sales amounted to $82.6 billion, showing 0.6% growth.

Fourth-quarter EPS was $0.65, a decrease of 56.7%; adjusted EPS was $1.86, a decrease of 1.1%.

The company provided 2021 guidance of adjusted operational sales growth of 8.8% and adjusted operational EPS growth of 16.4%.

Total Revenue

$22.5B

Previous year: $20.7B